| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.37 | 3e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.38 | 9e-11 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-10 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-09 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.34 | 2e-06 |